ISSN 2063-5346
For urgent queries please contact : +918130348310

Analysis of an Open Labelled Randomized Controlled Trial to Evaluate the Efficacy and Safety of Siddha Supplement (MAM Granules) along with Standard of Care Treatment in the management of RT-PCR Positive Pre-symptomatic COVID-19 patients at COVID-19 Care

Main Article Content

Manickavasagam Rengaraju, Anurag Srivastava, Saurabh Srivastava, Vimal Narayanan, Vivek Gupta, Rashmi Upadhayay, Shalini Smanla, Jitender Kumar, Vinod N.P, Aarthi Velmurugan, Kannan Muthiah, Sathiyarajeswaran Parameswaran, Kanakavalli Kadarkarai
» doi: 10.31838/ecb/2023.12.si6.325


COVID-19 emerges as the major global healthcare challenge of this century. In March 2021 during the initiation of the study, there is no proven herbal add-on therapy declared to combat COVID-19. Therefore, based on evidence from Pre-Clinical Studies, we tested the safety and efficacy of polyherbal drugs from India’s one of traditional medical systems i.e. Siddha Medical System namely “MAM Novel Siddha formulation” for the management of COVID-19. These Studies’ outcomes will be useful to explore the appropriate add-on Siddha drug in the management of COVID-19.

Article Details